About
CardioMech AS is a Norwegian medical technology company based in Trondheim, specializing in solutions for heart disease, particularly mitral valve repair. The company has developed a transcatheter mitral valve chordal repair device designed to reduce or eliminate mitral valve regurgitation by restoring the native anatomy of the mitral valve. This catheter-based device offers a minimally invasive option for patients, allowing for a transfemoral, transseptal approach that serves as an alternative to open-heart surgery. The CardioMech device targets degenerative mitral regurgitation, a serious cardiovascular condition. It is positioned as a first-line therapy for both eligible and ineligible patients for traditional surgical repair, potentially improving patient outcomes and expanding treatment options. With approximately $42 million raised in funding, including a recent $13 million round, CardioMech is focused on addressing significant unmet medical needs in cardiovascular care. The company collaborates with healthcare professionals and institutions to advance the development and commercialization of its innovative technology.
Technologies
Keywords
Company Information
-
Employees 10
-
Founded 2015
-
Total Funding $38738262
Location
Skaun, Trondelag, Norway, 7357
